104.47
+0.64
+(0.62%)
At close: April 16 at 4:00:02 PM EDT
105.60
+1.13
+(1.08%)
Pre-Market: 8:29:39 AM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| COLEMAN MARK H Director | Conversion of Exercise of derivative security | Jan 3, 2025 | 460,993 |
| JACOBSON MARK L Chief Operating Officer | Sale | Aug 9, 2024 | 5,783 |
| JEFFS ROGER A Director | Sale | Mar 15, 2024 | 167,668 |
| KAYE RANDALL E Officer | Purchase | Dec 23, 2015 | -- |
| PIZZIE NICK Chief Financial Officer | Sale | Feb 14, 2025 | 42,675 |
| SAAD MARK E Director | Sale | Sep 11, 2024 | 10,302 |
Related Tickers
ALNY Alnylam Pharmaceuticals, Inc.
230.50
-0.19%
TGTX TG Therapeutics, Inc.
38.21
-2.10%
MDGL Madrigal Pharmaceuticals, Inc.
307.78
-4.15%
IOVA Iovance Biotherapeutics, Inc.
3.0700
-4.95%
AVXL Anavex Life Sciences Corp.
8.84
-3.07%
SWTX SpringWorks Therapeutics, Inc.
37.74
+0.40%
VKTX Viking Therapeutics, Inc.
23.60
+2.12%
CYTK Cytokinetics, Incorporated
39.15
+1.53%
SRPT Sarepta Therapeutics, Inc.
53.94
-0.88%
ARWR Arrowhead Pharmaceuticals, Inc.
11.35
-11.81%